Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last ...

Two professional societies issued the first major set of evidence-based guidelines to define best practices in the use of ...

Shortly after obtaining a green light from the FDA, SetPoint Medical announced $140 million in new funding to juice the commercialization of its neuromodulation implant for rheumatoid art | Shortly ...

Speaking at a DGDA press briefing this morning (12 August), he said prices of 10 types of stents from three companies, Abbott, Boston Scientific and Medtronic, have already been reduced, with the new ...

Vinay Prasad, the U.S. Food and Drug Administration's top vaccine regulator, is returning to his post less than two weeks ...

The shares of biotech companies fell after news that ousted regulator Vinay Prasad is set to go back to the US Food and Drug Administration. Prasad had previously overruled his own scientific review ...

Insulet Corporation PODD reported second-quarter 2025 adjusted earnings per share (EPS) of $1.17, up 112.7% from the year-ago ...

Stifel’s Barry Bannister says stocks are due for a big drop and thinks investors should play defense with staples and ...

There are a number of emerging therapies in development for lowering lipoprotein(a), and later-stage trials are underway.Interest continues to grow in lipoprotein(a), commonly known as Lp(a), both as ...

Combining approximately $120 million from the former Helix II trust account (reflecting a final redemption rate of approximately 39% which is the second lowest redemption rate for a biotech de-SPAC ...

Cryofocus Medtech (Shanghai) Co., Ltd. ("Cryofocus" or the "Company," Stock Code: 6922.HK), a global innovator in minimally invasive interventional cryotherapy, last friday announced its unaudited ...

A new market analysis projects the Heart Block Therapeutics Market will grow from an estimated USD 3.5 billion in 2025 to a ...